Buprenorphine wafer for drug replacement therapy

• 1. 丁丙诺啡在制备术后疼痛的术前治疗药物中的用途 [P] . 中国专利： CN1829489B . 2010.12.15
• 2. 一种用于替代韩信草制备宫颈癌治疗药物的组合物及其测定方法 [P] . 中国专利： CN108635364B . 2019.04.05
• 3. Buprenorphine-wafer for drug substitution therapy [P] . 美国专利： US2019216797A1 . 2019-07-18

  机译： 丁丙诺啡晶片用于药物替代治疗

• 4. Buprenorphine-wafer for drug substitution therapy [P] . 美国专利： US9861628B2 . 2018-01-09

  机译： 丁丙诺啡晶片用于药物替代治疗

• 5. BUPRENORPHINE WAFER FOR DRUG SUBSTITUTION THERAPY [P] . 美国专利： US2018008595A1 . 2018-01-11

  机译： 丁丙诺啡片用于药物替代治疗

• 1. Twenty-four-hour ambulatory blood pressure changes in older patients with essential hypertension receiving monotherapy or dual combination antihypertensive drug therapy [J] . Pei-Pei LU, Ai-Hua HU, Xian-Liang ZHOU, 老年心脏病学杂志（英文版） . 2019,第004期
• 2. Metabolic and toxicological considerations of the opioid replacement therapy and analgesic drugs: Methadone and buprenorphine [J] . MoodyD.E. Expert opinion on drug metabolism & toxicology . 2013,第6期
• 3. Time-limited buprenorphine replacement therapy for opioid dependence: 2-year follow-up outcomes in relation to programme completion and current agonist therapy status. [J] . Kornor H, Waal H, Sandvik L Drug and alcohol review . 2007,第2期
• 4. Reduced pupil diameter in volunteers on stable buprenorphine maintenance therapy with telaprevir: A drug-drug interaction involving p-glycoprotein at the blood-brain barrier? [J] . MégarbaneB., AlhaddadH., DeclèvesX. Antimicrobial agents and chemotherapy. . 2012,第11期
• 5. Hormone replacement therapy andatherosclerosis-postmenopausal women and HRT:the fallen myth of the cardiovascular protectiveeffects of hormone replacement therapy [C] . Emilio H. Moriguchi, Jose Luiz C. Vieira International Symposium on Atherosclerosis . 2004
• 6. Class inequalities in prescription drug use: The case of hormone replacement therapy. [D] . Hosain, Yasmin Anjum. 2001
• 7. Evaluation of Clay-Functionalized Wafers and Films for Nicotine Replacement Therapy via Buccal Mucosa [O] . Joshua Boateng, Obinna Okeke 2019
• 8. Reduced Pupil Diameter in Volunteers on Stable Buprenorphine Maintenance Therapy with Telaprevir: a Drug-Drug Interaction Involving P-Glycoprotein at the Blood-Brain Barrier? [O] . Bruno Mégarbane, Hisham Alhaddad, Xavier Declèves 2012

• 1. TMR Non-Drug Therapy： the modernization of non-drug therapy [J] . Xiong-Zhi Wu . TMR非药物治疗 . 2018,第001期
• 2. Life after Addiction—Post-Operative Pain Management in an Obstetrical Patient on Long-Term Buprenorphine Therapy [J] . Kelly R Bowen ,Jonathan D Baum . 妇产科期刊（英文） . 2017,第9期
• 3. Drug combination therapy:providing evidence of significant superiority of a combination of drugs compared to the single agents [J] . Xiong-Zhi Wu1 . TMR药物联合治疗 . 2019,第001期
• 4. Highly Selective Photodynamic Therapy with a Short Drug-Light Interval Using a Cytotoxic Photosensitizer Porphyrus Envelope for Drug-Resistant Prostate Cancer Cells [J] . Youngsoon Hong ,Mizuho Inai ,Norihiro Honda . 临床医学国际期刊（英文） . 2018,第1期
• 5. 在稳定服用盐酸丁丙诺啡纳洛酮舌下片(Suboxone(R))的中国门诊受试者中比较盐酸丁丙诺啡纳洛酮舌下片(Suboxone(R))与安慰剂维持治疗阿片类药物依赖的随机、双盲、对照的多中心研究 [C] . 王绪轶 ,江海峰 ,赵敏 . 中国药物滥用防治协会第六次会员代表大会暨中国药物滥用防治协会第十六届学术会议 . 2017
• 6. 不同CRRT治疗剂量对接受连续性肾脏替代治疗的脓毒症患者美罗培南血浆药物浓度的影响 [A] . 王迎鑫 . 2017